J Clin Neurol 2019;15(4):454–460 / https://doi.org/10.3988/jcn.2019.15.4.454
The authors hope to add the Acknowledgements, which have been omitted from the initial manuscript. Also, the authors hope to revise the Conflict of Interest as follows:
Conflicts of Interest
Kim SH has received a grant from the National Research Foundation of Korea.
Kim Y, Jung JY, Park NY, Jang HM and Hyun JW report no disclosure.
Kim HJ has lectured, consulted and received honoraria from Bayer Schering Pharma, Biogen, Celltrion, Eisai, Genzyme, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Teva-Handok and UCB; received a grant from the Ministry of Science & ICT; accepted research funding from Genzyme, Kael-GemVax, Merck Serono, Teva-Handok and UCB; serves on a steering committee for MedImmune; is a coeditor for the Multiple Sclerosis Journal—Experimental, Translational and Clinical, and an associated editor for the Journal of Clinical Neurology.
Acknowledgements
This work was supported by the National Research Foundation of Korea (Grant No. NRF-2016R1D1A1A09916480).
Biogen Idec provided the STRATIFY Gen2 assay free-of-charge for some of our samples, as per normal clinical practice.